These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10369544)

  • 41. Childhood pemphigus vulgaris treated with dapsone: a case report.
    Bjarnason B; Skoglund C; Flosadóttir E
    Pediatr Dermatol; 1998; 15(5):381-3. PubMed ID: 9796590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pemphigus: a review].
    Joly P; Sin C
    Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral pemphigus vulgaris in children and adolescents: a review of the literature and a case report.
    Ariyawardana A; Tilakaratne WM; Dissanayake M; Vitanaarachchi N; Basnayake LK; Sitheeque MA; Ranasinghe AW
    Int J Paediatr Dent; 2005 Jul; 15(4):287-93. PubMed ID: 16011788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pemphigus].
    Lapeyre-Liénard H; Joly P
    Presse Med; 2010 Oct; 39(10):1066-70. PubMed ID: 20817387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pemphigus vulgaris in three adolescents: the course of the disease.
    Popadic S; Medenica L; Skiljevic D; Djakovic Z; Nikolic M
    Australas J Dermatol; 2011 Aug; 52(3):e3-7. PubMed ID: 21834807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
    Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Minocycline is a useful adjuvant therapy for pemphigus.
    Gaspar ZS; Walkden V; Wojnarowska F
    Australas J Dermatol; 1996 May; 37(2):93-5. PubMed ID: 8687335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of pemphigus vulgaris. An overview in Mexico.
    Tirado-Sánchez A; León-Dorantes G
    Allergol Immunopathol (Madr); 2006; 34(1):10-6. PubMed ID: 16540065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonendemic pemphigus foliaceus in children.
    Metry DW; Hebert AA; Jordon RE
    J Am Acad Dermatol; 2002 Mar; 46(3):419-22. PubMed ID: 11862179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Statistical observations of pemphigus at the Nara University Hospital from 1975 to 1989].
    Nakatani C; Matsuoka A; Muramatsu T; Miyagawa S; Sakamoto K; Shirai T
    Nihon Hifuka Gakkai Zasshi; 1991 Jul; 101(8):831-5. PubMed ID: 1942587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent Asymptomatic Sigmoid Diverticular Perforation in a Patient with Pemphigus Vulgaris on Immunosuppressive Therapy: A Case Report.
    Saliba C; Rabah H; Nicolas G; Emmanuel N; Sleiman A; Hashem M; Hussein R; El Masri A; Abboud R; Fawaz M; Haidar Ahmad H
    Am J Case Rep; 2019 May; 20():735-738. PubMed ID: 31123245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pemphigus: analysis of 1209 cases.
    Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Esmaili N; Balighi K; Hallaji Z; Barzegari M; Akhiani M; Ghodsi Z; Mortazavi H; Naraghi Z
    Int J Dermatol; 2005 Jun; 44(6):470-6. PubMed ID: 15941433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pemphigus vulgaris: a clinical study of 44 cases over a 20-year period.
    Svecova D
    Int J Dermatol; 2015 Oct; 54(10):1138-44. PubMed ID: 26394602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris.
    Chams-Davatchi C; Mortazavizadeh A; Daneshpazhooh M; Davatchi F; Balighi K; Esmaili N; Akhyani M; Hallaji Z; Seirafi H; Mortazavi H
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1285-92. PubMed ID: 23062214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
    Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
    J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris.
    Mabrouk D; Ahmed AR
    Pediatr Dermatol; 2011; 28(5):485-93. PubMed ID: 21883426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of pemphigus.
    Piamphongsant T; Ophaswongse S
    Int J Dermatol; 1991 Feb; 30(2):139-46. PubMed ID: 2001906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
    Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
    J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.